Adverse events following immunization with pentavalent vaccine in a tertiary care hospital

Factors Associated with Adverse Outcome in Pediatric Febrile Neutropenia: Results from a Tertiary Care Hospital

Background Febrile neutropenia with childhood cancer alters the outcome significantly. To study the clinical and laboratory parameters, which predict the outcome among cancer patients with febrile neutropenia this study was undertaken. Materials and Methods The study included children less than 18 years with febrile neutropenia episodes. Clinical and hematological / laboratory parameters were r...

Adverse events following immunization: perception and evidence.

PURPOSE OF REVIEW The aim of this article is to highlight the evidence on new and ongoing vaccine safety concerns in the light of several vaccines recently licensed and others made available and recommended more widely. RECENT FINDINGS There is increasingly convincing epidemiologic and laboratory evidence against a causal relation of several alleged adverse events following immunization. The ...

Causality assessment of adverse events following immunization.

A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization

Rotavirus is the most common cause of diarrhea leading to hospitalization in young children. Rotavirus vaccines are available in Canada but have not been introduced in all provinces. In a controlled trial, 2 study sites (Prince Edward Island and the Capital District Health Authority (District 9, Nova Scotia) introduced universal rotavirus vaccine programs for infants at 2 and 4 months of age be...

Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012

INTRODUCTION Post-licensure vaccine safety studies are essential to identify uncommon events that may be difficult to assess during pre-licensure studies. The aim of our study was to evaluate the safety of serogroup C meningococcal conjugate (MCC) vaccine in Tuscany from 2005 to 2012. METHODS All adverse events (AEs) to MCC vaccine notified from 2005 to 2012 were obtained from the regional he...